arrow
S

Shungo Hikoso

Nara Medical University
H指数:38
被引数:8,148

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Prognostic Implications of the 2025 ASE guidelines for the Evaluation of Left Ventricular Diastolic Function in Heart Failure with Preserved Ejection Fraction and Atrial Fibrillation.

2025年ASE指南对射血分数保留的心力衰竭合并心房颤动患者左心室舒张功能评估的预后意义。

2026-09-030
PRE
Impact of estimated total blood volume on NT-proBNP response to angiotensin receptor-neprilysin inhibition in acute heart failure: Insights from the PREMIER study

估算总血容量对急性心力衰竭中血管紧张素受体-中性肽链内切酶抑制剂治疗下NT-proBNP反应的影响:来自PREMIER研究的见解

2026-08-010
PRE
ALID score for treatment-effect heterogeneity of adjunctive low-voltage area ablation in persistent atrial fibrillation: A post hoc analysis of SUPPRESS-AF

低电压区域消融作为附加治疗在持续性心房颤动中治疗效果异质性的ALID评分:SUPPRESS-AF研究的回顾性分析

2026-07-010
OAAI
The association of longitudinal NT-proBNP levels with echocardiographic measurements in heart failure with preserved ejection fraction: Insights from the PURSUIT-HFpEF registry

射血分数保留的心力衰竭患者中纵向NT-proBNP水平与超声心动图测量的关联:PURSUIT-HFpEF登记研究的见解

2026-05-090
OAAI
Prevalence and Clinical Characteristics of Patients With Heart Failure With Preserved Ejection Fraction Who Meet the Obesity-Related Eligibility Criteria for Subcutaneous Incretin Receptor Agonists in Japan ― Insights From the PARACLETE Study ―

日本符合皮下胰高血糖素样肽-1受体激动剂肥胖相关适用标准的射血分数保留的心力衰竭患者的患病率及临床特征——来自PARACLETE研究的见解

2026-04-012
PRE
Guideline-directed medical therapy and hypotension after initiation of vericiguat: Insights from the VERIFY-HF study

基于VERIFY-HF研究的指导性医疗疗法与启动vericiguat后的低血压:洞见

2026-03-260
OAAI
Left atrial functional deterioration after beyond-pulmonary vein isolation strategy predominantly consisting of linear ablation: Insights from the EARNEST-PVI Trial

线性消融为主要策略的肺静脉隔离后左心房功能恶化的机制:EARNEST-PVI试验的启示

2026-03-140
PRE
Win ratio analysis of low-voltage area ablation in persistent atrial fibrillation: sub-analysis of SUPPRESS-AF

持续性心房颤动中低电压区域消融的胜率分析:SUPPRESS-AF的亚组分析

2026-01-010
PRE
Prevalence, Characteristics, and Pharmacological Strategies in Patients With Heart Failure With Supranormal Ejection Fraction ― Insights From the PARACLETE Study ―

心力超射射血分数患者的患病率、特征及药物治疗策略——来自PARACLETE研究的研究见解

2025-12-010
PRE
Comparison of drug-coated versus conventional balloons for the side branch of the bifurcation lesion - multicenter randomized controlled study - (O CVC-BIF): Design and rationale
2025-12-012
PRE
Cardiothoracic ratio as a prognostic marker in heart failure with preserved ejection fraction

心胸比率作为射血分数保留的心力衰竭的预后标志物

2025-09-140
PRE
JCS/JHFS 2025 Guideline on Diagnosis and Treatment of Heart Failure

JCS/JHFS 2025 心力衰竭诊断与治疗指南

2025-09-010
PRE
Impact of renal function on the efficacy of low-voltage area ablation after pulmonary vein isolation: a sub-analysis of the SUPPRESS-AF trial

肾功能对肺静脉隔离后低电压区域消融疗效的影响:SUPPRESS-AF试验的亚组分析

2025-09-010
OAAI